Michael Rosove, MD
Clinical Professor, Department of Medicine, Hematology/Oncology
Physician, Department of Medicine, Hematology/Oncology
Member,
Cancer and Stem Cell Biology
Specialty
Cancer/Medical Oncology,
Hematology,
Internal Medicine
Institutional Affiliation
Ronald Reagan UCLA Medical Center
Languages
English
Education
Fellowships
Medicine, Hematology/Oncology, Columbia Presbyterian Medical Center, 1977 - 1978
Hematology/Oncology, UCLA School of Medicine, 1976 - 1979
Internship
Internal Medicine, UCLA School of Medicine, 1973 - 1974
Degree
MD, UCLA School of Medicine, 1973
Residency
Internal Medicine, UCLA School of Medicine, 1974 - 1976
Board Certifications
Hematology, American Board of Internal Medicine, 1982
Medical Oncology, American Board of Internal Medicine, 1981
Internal Medicine, American Board of Internal Medicine, 1976
Contact Information
Phone
(310) 206-6909
- Hematology/Oncology Information and Patient Appointments
(888) 662-8252
- Community Oncology Practice Information and Patient Appointments
(310) 794-4955
- Community Oncology Practice Information
Clinical Interests
Hemostasis and Thrombosis,
General Hematology,
Myeloproliferative and Myelodysplastic Disorders,
Hematologic Malignancies,
Head and Neck Cancer,
Lung Cancer,
General Medical Oncology
Scientific Interests
Dr. Michael Rosove's research focuses on disorders of hemostasis and thrombosis, and he also has an interest in hematological malignancies and hepatocellular carcinoma.
Highlighted Publications
Marder VJ, Rosove MH, Minning DM. Foundation and sites of action of antithrombotic agents. Best Pract Res Clin Haematol. 2004 Mar;17(1):3-22.
Rosove MH. Platelet glycoprotein IIb/IIIa inhibitors. Best Pract Res Clin Haematol. 2004 Mar;17(1):65-76.
Salomon O, Zivelin A, Livnat T, Dardik R, Loewenthal R, Avishai O, Steinberg DM, Rosove MH, O'Connell N, Lee CA, Seligsohn U. Prevalence, causes, and characterization of factor XI inhibitors in patients with inherited factor XI deficiency. Blood. 2003 Jun 15;101(12):4783-8. Epub 2003 Feb 13.